Tag archive for ‘Peter Langmuir’
By pharmanewsdaily On Tuesday, December 3rd, 2019
0 Comments

Incyte secures FDA priority review for pemigatinib in cholangiocarcinoma

Delaware-based pharma company Incyte has secured priority review for pemigatinib from the US Food and Drug Administration (FDA) for the treatment of locally advanced or metastatic cholangiocarcinoma. The priority More...